ISLAMABAD, (MANEND NEWS): Embassy of Pakistan in Tokyo has
formally accepted 130,000 rapid testing kits for Covid-19 from a
Japanese healthcare company Fujirebio, after NCOC’s approval.
Fujirebio is well known for its research, development and innovation-
based products. According to the company, Espline is Japan’s first kit
that detects covid-19 antigens in less than 30 minutes, offering a
simple procedure using nasal swab. The kits have an evidential
concordance rate of more than 90% and have been used at Japanese
airports in the past.
The kits will be airlifted from Narita Airport in Tokyo for Islamabad
International Airport. On the directions of NCOC, National Disaster
Management Authority (NDMA) will be assisting with the logistics once
the consignment arrives in Pakistan early next week.
National Institute of Health (NIH), Islamabad will implement a
distribution plan for use of these kits in different healthcare facilities
across Pakistan. On Friday Ambassador Imtiaz Ahmad welcomed the
company delegation at the Embassy and thanked them for the
On behalf of Fujirebio, Ryoichi Nagashima and Ms. Keiko Yamamoto
showed their gratitude for a quick response from the Government of
Pakistan in accepting the donation, while appreciating support
extended by the Embassy and its officers in smooth coordination.
Through a series of meetings with the Japanese team and field
inspection visits, Trade & Investment Counselor at the Embassy has
been acting as the focal point for providing a channel of close
coordination between the donor company and the consignee agency in
The Mission also acknowledges and appreciates efforts of two overseas
Pakistanis living in Japan, Ghalib Hussain and Farid Hussain who
played a very important role in connecting the donor company
Fujirebio with the Embassy of Pakistan in Tokyo. Efforts of Mission are
complemented by Pakistani community in Japan who not only earn a
good name for Pakistan but also provide access to their networks for a